Gastric MALT lymphoma with t(14;18)(q32;q21) involving IGH and BCL2 genes that responded to Helicobacter pylori eradication

Journal of Clinical Pathology

Volumn 60, Issue 10, 2007, Pages 1171-1173

  Nakamura, Shotaro ^a,b   Ye, Hongtao ^a   Bacon, Chris M ^a   Liu, Hongxiang ^a   Goatly, Alison ^a   Matsumoto, Takayuki ^b   Koga, Hideki ^b   Umeno, Junji ^b   Ohji, Yutaka ^b   Yao, Takashi ^b   Nakahara, Tsukasa ^c   Iida, Mitsuo ^b   Du, Ming Qing ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KYUSHU UNIVERSITY   (Japan)

^c Kyushu Central Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; FLUORODEOXYGLUCOSE F 18; PROTEIN BCL 2; RABEPRAZOLE;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; ESOPHAGOGASTRODUODENOSCOPY; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; UREA BREATH TEST;

EID: 35349001152     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.048207     Document Type: Article

References (14)

1. Du MQ, Atherton JC. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut 2006;55:886-93.
2. Ye H, Gong L, Liu H, et al. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J Pathol 2005;205:293-301.
3. Sagaert X, de Paepe P, Libbrecht L, et al. Forkhead box P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J Clin Oncol 2006;24:2490-7.
4. Willis TG, Dyer MJS. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 2000;96:808-22.
5. Nakamura S, Matsumoto T, Suekane H, et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut 2001;48:454-60.
6. Rohatiner A, d'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994;5:397-400.
7. Copie-Bergman C, Gaulard P, Lavergne-Slove A, et al. Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 2003;52:1656.
8. Tzankov A, Hittmair A, Müller-Hermelink HK, et al. Primary gastric follicular lymphoma with parafollicular monocytoid B-cells and lymphoepithelial lesions, mimicking extranodal marginal zone lymphoma of MALT. Virchows Arch 2002;441:614-17.
9. Nowakowski GS, Dewald GW, Hoyer JD, et al. Interphase fluorescence in situ hybridisation with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol 2005;130:36-42.
10. Aiello A, Du MQ, Diss TC, et al. Simultaneous phenotypically distinct but clonally identical mucosa-associated lymphoid tissue and follicular lymphoma in a patient with Sjögren's syndrome. Blood 1999;94:2247-51.
11. Libra M, De Re V, Gloghini A, et al. Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection. Haematologica 2004;89:873-4.
12. Liu H, Ye H, Ruskoné-Fourmestraux A, et al. t(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002;122:1286-94.
13. Wündisch T, Thiede C, Morgner A, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005;23:8018-24.
14. Fischbach W, Goebeler-Kolve M, Starostik P, et al. Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 2002;360:547-8.